Screener/Healthcare/Biotechnology

CRSP

CRISPR Therapeutics AGNASDAQ
$46.52-0.36 (-0.78%)
Mid CapUnder $50HealthcareHigh Beta
$30.04
$78.48
$45.12
$46.96
EPS (TTM)$-6.50
P/E Ratio—
Dividend Yield—
Market Cap$4.50B
Volume853K
Prev Close$46.88
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$864K-$130.6M$-1.35—-15117.2%
Q3 '25$889K-$106.4M$-1.17—-11973.1%
Q2 '25$892K-$208.5M$-2.40—-23379.9%
Q1 '25$865K-$136.0M$-1.58—-15722.1%
Q4 '24$35.7M-$37.3M$-0.42—-104.5%
Q3 '24$602K-$85.9M$-1.01—-14276.1%
Q2 '24$517K-$126.4M$-1.49—-24450.3%
Q1 '24$504K-$116.6M$-1.43—-23133.1%
Get Your Daily Market Recap